☰

Mahmoud A. Abouraya, Ph.D. - Publications

Affiliations: 
2011 University of Wisconsin, Madison, Madison, WI 
Area:
Pharmacology, Toxicology
Tree Info Grants Similar researchers PubMed Report error

4 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2012 Sacco JC, Abouraya M, Motsinger-Reif A, Yale SH, McCarty CA, Trepanier LA. Evaluation of polymorphisms in the sulfonamide detoxification genes NAT2, CYB5A, and CYB5R3 in patients with sulfonamide hypersensitivity. Pharmacogenetics and Genomics. 22: 733-40. PMID 22850190 DOI: 10.1097/Fpc.0B013E328357A735  0.579
2012 Abouraya M, Sacco JC, Hayes K, Thomas S, Kitchens CS, Trepanier LA. Dapsone-associated methemoglobinemia in a patient with slow NAT2*5B haplotype and impaired cytochrome b5 reductase activity. Journal of Clinical Pharmacology. 52: 272-8. PMID 21422237 DOI: 10.1177/0091270010393343  0.615
2011 Abouraya M, Sacco JC, Kahl BS, Trepanier LA. Evaluation of sulfonamide detoxification pathways in haematologic malignancy patients prior to intermittent trimethoprim-sulfamethoxazole prophylaxis. British Journal of Clinical Pharmacology. 71: 566-74. PMID 21204907 DOI: 10.1111/J.1365-2125.2010.03889.X  0.593
2010 Bhusari S, Abouraya M, Padilla ML, Pinkerton ME, Drescher NJ, Sacco JC, Trepanier LA. Combined ascorbate and glutathione deficiency leads to decreased cytochrome b5 expression and impaired reduction of sulfamethoxazole hydroxylamine. Archives of Toxicology. 84: 597-607. PMID 20221587 DOI: 10.1007/S00204-010-0530-Z  0.576
Show low-probability matches.